Aderem A: The MARCKS brothers: a family of protein kinase C substrates. Cell 71:713-716, 1992 [PubMed] Aghajanian GK, Marek GJ: Serotonin and hallucinogens. Neuropsychopharmacology 21 (2, suppl):16S-23S, 1999

Akil M, Kolachana BS, Rothmond DA, et al: Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 23:2008-2013, 2003 [PubMed]

Alger BE: Endocannabinoid identification in the brain: studies of breakdown lead to breakthrough, and there may be NO hope. Sci STKE 2005(309):pe51, 2005

Alhquist R: A study of adrenergic receptors. Am J Physiol 153:586-590, 1948

Altier C, Zamponi GW: Opioid, cheating on its receptors, exacerbates pain. Nat Neurosci 9:1534-1540, 2006

Ali A, Hoeflich KP, Woodgett JR: Glycogen synthase kinase-3: properties, functions, and regulation. Chem Rev 101:2527-2540, 2001 [PubMed]

Amat J, Baratta MV, Paul E, et al: Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nat Neurosci 8:365-371, 2005 [PubMed]

Anden NE, Magnusson T, Rosengren E: On the presence of dihydroxyphenylalanine decarboxylase in nerves. Experientia 20:328-329, 1964 [PubMed]

Andrade R, Malenka RC, Nicoll RA: A G protein couples serotonin and GABAB receptors to the same channels in hippocampus. Science 234:1261-1265, 1986 [PubMed]

Ansorge MS, Zhou M, Lira A, et al: Early life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306:879-881, 2004 [PubMed] Atkins CM, Selcher JC, Petraitis JJ, et al: The MAPK cascade is required for mammalian associative learning. Nat Neurosci 1:602-609, 1998 [PubMed] Axelrod J: Phospholipase A2 and G proteins. Trends Neurosci 18:64-65, 1995 [PubMed]

Axelrod J, Burch RM, Jelsema CL: Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengers. Trends Neurosci 11:117-123, 1988 [PubMed]

Ayalon G, Stern-Bach Y: Functional assembly of AMPA and kainate receptors is mediated by several discrete protein-protein interactions. Neuron 31:103-113, 2001 [PubMed]

Barria A, Malinow R: NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII. Neuron 48:289-301, 2005 [PubMed]

Baum AE, Akula N, Cabanero M, et al: A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 13:197-207, 2008 [PubMed]

Bauman AL, Apparsundaram S, Ramamoorthy S, et al: Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J Neurosci 20:7571-7578, 2000 [PubMed]

Bekkers JM, Stevens CF: NMDA and non-NMDA receptors are co-localized at individual excitatory synapses in cultured rat hippocampus. Nature 341:230-233, 1989 [PubMed]

Bell C, Abrams J, Nutt D: Tryptophan depletion and its implications for psychiatry. Br J Psychiatry 178:399-405, 2001 [PubMed]

Beaulieu JM, Sotnikova TD, Yao WD, et al: Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci U S A 101:5099-5104, 2004 [PubMed]

Bebchuk JM, Arfken CL, Dolan-Manji S, et al: A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania. Arch Gen Psychiatry 57:95-97, 2000 [PubMed]

Beneyto M, Kristiansen LV, Oni-Orisan A, et al: Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Neuropsychopharmacology 32:1888-1902, 2007 [PubMed]

Ben Mamou C, Gamache K, Nader K: NMDA receptors are critical for unleashing consolidated auditory fear memories. Nat Neurosci 9:1237-1239, 2006 Bhalla US, Iyengar R: Emergent properties of networks of biological signaling pathways. Science 283:381-387, 1999 [PubMed]

Birnbaum SG, Yuan PX, Wang M, et al: Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science 306:882-884, 2004 [PubMed]

Blier P, Pineyro G, el Mansari M, et al: Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann N Y Acad Sci 861:204-216, 1998 [PubMed]

Blum S, Moore AN, Adams F, et al: A mitogen-activated protein kinase cascade in the CA1/CA2 subfield of the dorsal hippocampus is essential for long-term spatial memory. J Neurosci 19:3535-3544, 1999 [PubMed]

Bogdansky D, Pletscher A, Brodie B, et al: Identification and assay of serotonin in brain. J Pharmacol Exp Ther 117:88-98, 1956

Bonni A, Brunet A, West AE, et al: Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286:1358-1362, 1999 [PubMed]

Bourne HR, Nicoll R: Molecular machines integrate coincident synaptic signals. Cell 72 (suppl):65-75, 1993 Bouvier M: Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci 2:274-286, 2001 [PubMed]

Bown CD, Wang JF, Chen B, et al: Regulation of ER stress proteins by valproate: therapeutic implications. Bipolar Disord 4:145-151, 2002 [PubMed]

Brambilla D, Chapman D, Greene R: Adenosine mediation of presynaptic feedback inhibition of glutamate release. Neuron 46:275-283, 2005 [PubMed]

Brandish PE, Su M, Holder DJ: Regulation of gene expression by lithium and depletion of inositol in slices of adult rat cortex. Neuron 45:861-872, 2005 [PubMed]

Brodie B: The immediate action of an intravenous injection of blood serum. J Physiol (Lond) 26:48-71, 1900 [PubMed]

Bruinvels AT, Palacios JM, Hoyer D: 5-Hydroxytryptamine1 recognition sites in rat brain: heterogeneity of non-5-hydroxytryptamine1A/1C binding sites revealed by quantitative receptor autoradiography. Neuroscience 53:465-473, 1993 [PubMed]

Brunet A, Datta SR, Greenberg ME: Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 11:297-305, 2001 [PubMed]

Bruno V, Battaglia G, Copani A, et al: An activity-dependent switch from facilitation to inhibition in the control of excitotoxicity by group I metabotropic glutamate receptors. Eur J Neurosci 13:1469-1478, 2001 [PubMed]

Bruss M, Porzgen P, Bryan-Lluka LJ, et al: The rat norepinephrine transporter: molecular cloning from PC12 cells and functional expression. Brain Res Mol Brain Res 52:257-262, 1997 [PubMed]

Bruss M, Bonisch H, Buhlen M, et al: Modified ligand binding to the naturally occurring Cys-124 variant of the human serotonin 5-HT1B receptor. Pharmacogenetics 9:95-102, 1999 [PubMed]

Bylund DB, Eikenberg DC, Hieble JP, et al: International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121-136, 1994 [PubMed]

Cahill L, Prins B, Weber M, et al: Beta-adrenergic activation and memory for emotional events. Nature 371:702-704, 1994 [PubMed]

Carlezon WA Jr, Nestler EJ: Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? Trends Neurosci 25:610-615, 2002 [PubMed]

Carlson PJ, Singh JB, Zarate CA Jr, et al: Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. NeuroRx 3:22-41, 2006 [PubMed]

Carman CV, Benovic JL: G-protein-coupled receptors: turn-ons and turn-offs. Curr Opin Neurobiol 8:335-344, 1998 [PubMed]

Casado M, Bendahan A, Zafra F, et al: Phosphorylation and modulation of brain glutamate transporters by protein kinase C. J Biol Chem 268:27313-27317, 1993 [PubMed]

Caspi A, Sugden K, Moffitt TE, et al: Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-389, 2003 [PubMed]

Catapano L, Manji HK: G protein-coupled receptors in major psychiatric disorders. Biochim Biophys Acta 1768:976-993, 2007 [PubMed]

Chavez AE, Singer JH, Diamond JS: Fast neurotransmitter release triggered by Ca influx through AMPA-type glutamate receptors. Nature 443:705-708, 2006 [PubMed]

Chen G, Manji HK: The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Curr Opin Psychiatry 19:313-323, 2006 [PubMed]

Chen G, Hasanat KA, Bebchuk JM, et al: Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants. Psychosom Med 61:599-617, 1999 [PubMed]

Chen ZY, Jing D, Bath KG, et al: Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 314:140-143, 2006 [PubMed]

Chenn A, Walsh CA: Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 297:365-369, 2002 [PubMed]

Clark D, White FJ: D1 dopamine receptor—the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications. Synapse 1:347-388, 1987 [PubMed]

Cohen P, Frame S: The renaissance of GSK3. Nat Rev Mol Cell Biol 2:769-776, 2001 [PubMed]

Conn PJ, Pin JP: Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205-237, 1997 [PubMed]

Conn PJ, Sanders-Bush E: Central serotonin receptors: effector systems, physiological roles and regulation. Psychopharmacology (Berl) 92:267-277, 1987 [PubMed]

Conradt M, Stoffel W: Inhibition of the high-affinity brain glutamate transporter GLAST-1 via direct phosphorylation. J Neurochem 68:1244-1251, 1997 [PubMed]

Cooper JR, Bloom FE, Roth RH: The Biochemical Basis of Neuropharmacology, 7th Edition. New York, Oxford University Press, 2001

Coupland N, Zedkova L, Sanghera G, et al: Response to pentagastrin after acute phenylalanine and tyrosine depletion in healthy men: a pilot study. J Psychiatry Neurosci 26:247-251, 2001 [PubMed]

Coyle JT, Tsai G, Goff DC: Ionotropic glutamate receptors as therapeutic targets in schizophrenia. Curr Drug Targets CNS Neurol Disord 1(2):183-189, 2002 [PubMed]

Crawley JN, Glowa JR, Majewska MD, et al: Anxiolytic activity of an endogenous adrenal steroid. Brain Res 398:382-385, 1986 [PubMed]

Crow T, Xue-Bian JJ, Siddiqi V, et al: Phosphorylation of mitogen-activated protein kinase by one-trial and multi-trial classical conditioning. J Neurosci 18:3480-3487, 1998 [PubMed]

Dahlstrom A: Regional distribution of brain catecholamines and serotonin. Neurosci Res Program Bull 9:197-205, 1971 [PubMed]

D'Amato RJ, Largent BL, Snowman AM, et al: Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine. J Pharmacol Exp Ther 242:364-371, 1987 [PubMed]

Datta SR, Dudek H, Tao X, et al: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241, 1997 [PubMed]

Davies SP, Reddy H, Caivano M, et al: Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351(pt 1):95-105, 2000

Dawson TM, Snyder SH: Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci 14:5147-5159, 1994 [PubMed]

Descarries L, Watkins KC, Garcia S, et al: The serotonin neurons in nucleus raphe dorsalis of adult rat: a light and electron microscope radioautographic study. J Comp Neurol 207:239-254, 1982 [PubMed]

De Vivo M, Maayani S: Stimulation and inhibition of adenylyl cyclase by distinct 5-hydroxytryptamine receptors. Biochem Pharmacol 40:1551-1558, 1990

Dingledine R, Borges K, Bowie D, et al: The glutamate receptor ion channels. Pharmacol Rev 51:7-61, 1999 [PubMed]

Dong Y, Green T, Saal D, et al: CREB modulates excitability of nucleus accumbens neurons. Nat Neurosci 9:475-477, 2006 [PubMed]

Drager UC: Retinoic acid signaling in the functioning brain. Sci STKE (324):pe10, 2006

Drevets WC, Bogers W, Raichle ME: Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol 12:527-544, 2002 [PubMed]

Drury AN, Szent-Gysrgyi A: The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 68:213-237, 1929 [PubMed]

Du J, Feng L, Yang F, et al: Activity- and Ca(2+)-dependent modulation of surface expression of brain-derived neurotrophic factor receptors in hippocampal neurons. J Cell Biol 150:1423-1434, 2000 [PubMed]

Du J, Gould TD, Manji HK: Neurotrophic signaling in mood disorders, in Signal Transduction and Human Disease. Edited by Finkel T, Gutkind JS. New York, Wiley, 2003, pp 411-445

Du J, Wei Y, Chen Z, et al: The anticonvulsants lamotrigine, riluzole and valproate differentially regulate AMPA receptor trafficking: relationship to clinical effects in mood disorders. Neuropsychopharmacology 32:793-802, 2007 [PubMed]

Duman RS: Synaptic plasticity and mood disorders. Mol Psychiatry 7 (suppl 1):S29-S34, 2002

Dunlop BW, Nemeroff CB: The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 64:327-337, 2007 [PubMed] Eide EJ, Virshup DM: Casein kinase I: another cog in the circadian clockworks. Chronobiol Int 18:389-398, 2001 [PubMed]

Einat H, Manji HK: Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder. Biol Psychiatry 59:1160-1171, 2006 [PubMed]

Einat H, Yuan P, Szabo ST, et al: Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder. Neuropsychobiology 55:123-131, 2007 [PubMed]

Encinas JM, Vaahtokari A, Enikolopov G: Fluoxetine targets early progenitor cells in the adult brain. Proc Natl Acad Sci U S A 103:8233-8238, 2006 [PubMed]

English JD, Sweatt JD: Activation of p42 mitogen-activated protein kinase in hippocampal long term potentiation. J Biol Chem 271:24329-24332, 1996 [PubMed]

English JD, Sweatt JD: A requirement for the mitogen-activated protein kinase cascade in hippocampal long term potentiation. J Biol Chem 272:19103-19106, 1997 [PubMed]

Evans DL, Leary JH 3rd, Jaso-Friedmann L: Nonspecific cytotoxic cells and innate immunity: regulation by programmed cell death. Dev Comp Immunol 25:791-805, 2001 [PubMed]

Faden AI, Demediuk P, Panter SS, et al: The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244:798-800, 1989 [PubMed]

Fields RD, Stevens-Graham B: New insights into neuron-glia communication. Science 298:556-562, 2002 [PubMed]

Foote SL, Bloom FE, Aston-Jones G: Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev 63:844-914, 1983 [PubMed]

Frame S, Cohen P: GSK3 takes centre stage more than 20 years after its discovery. Biochem J 359 (pt 1):1-16, 2001

Freedman R, Coon H, Myles-Worsley M, et al: Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A 94:587-592, 1997 [PubMed]

Frodl T, Schule C, Schmitt G, et al: Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry 64:410-416, 2007 [PubMed]

Frye CA, Scalise TJ: Anti-seizure effects of progesterone and 3cc,5tt-THP in kainic acid and perforant pathway models of epilepsy. Psychoneuroendocrinology 25:407-420, 2000 [PubMed]

Fryer RH, Kaplan DR, Feinstein SC, et al: Developmental and mature expression of full-length and truncated TrkB receptors in the rat forebrain. J Comp Neurol 374:21-40, 1996 [PubMed]

Fukunaga K, Miyamoto E: Role of MAP kinase in neurons. Mol Neurobiol 16:79-95, 1998 [PubMed] Gaddum JH, Picarelli ZP: Two kinds of tryptamine receptor. Br J Pharmacol 12:323-328, 1957 [PubMed]

Galli A, DeFelice LJ, Duke BJ, et al: Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants. J Exp Biol 198(pt 10):2197-2212, 1995

Galli A, Blakely RD, DeFelice LJ: Norepinephrine transporters have channel modes of conduction. Proc Natl Acad Sci U S A 93:8671-866, 1996 [PubMed]

Genoux D, Haditsch U, Knobloch M, et al: Protein phosphatase 1 is a molecular constraint on learning and memory. Nature 418:970-975, 2002 [PubMed]

Gerber DJ, Hall D, Miyakawa T, et al: Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc Natl Acad Sci U S A 100:8993-8998, 2003 [PubMed]

Glykys J, Peng Z, Chandra D, et al: A new naturally occurring GABA(A) receptor subunit partnership with high sensitivity to ethanol. Nat Neurosci 10:40-48, 2007 [PubMed]

Gonzalez M, Ruggiero FP, Chang Q, et al: Disruption of Trkb-mediated signaling induces disassembly of postsynaptic receptor clusters at neuromuscular junctions. Neuron 24:567-583, 1999 [PubMed]

Gonzalez-Maeso J, Weisstaub NV, Zhou M, et al: Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 53:439-452, 2007 [PubMed]

Goodwin FK, Jamison KR: Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression. New York, Oxford University Press, 2007 Gould T, Manji H: Signaling pathways in the pathophysiology of mood disorders. J Psychosom Res 53:687-697, 2002 [PubMed]

Gould T, Manji HK: Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 30:1223-1237, 2005 [PubMed]

Gould T, Chen G, Manji HK: Mood stabilizer psychopharmacology. Clinical Neuroscience Research 2:193-212, 2002

Gould T, Gray NA, Manji HK: The cellular neurobiology of severe mood and anxiety disorders: implications for the development of novel therapeutics, in Molecular Neurobiology for the Clinician (Review of Psychiatry Series, Vol 22, No 3; Oldham JM, Riba MB, series eds). Edited by Charney DS. Washington, DC, American Psychiatric Publishing, 2003, pp 123-227

Greengard P: The neurobiology of dopamine signaling. Biosci Rep 21:247-269, 2001a Greengard P: The neurobiology of slow synaptic transmission. Science 294:1024-1030, 2001b

Grimes CA, Jope RS: The multifaceted roles of glycogen synthase kinase 3p in cellular signaling. Prog Neurobiol 65:391-426, 2001 [PubMed]

Gross C, Zhuang X, Stark K, et al: Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416:396-400, 2002 [PubMed]

Guillin O, Diaz J, Carroll P, et al: BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411:86-89, 2001 [PubMed]

Habert E, Graham D, Tahraoui L, et al: Characterization of [3H]paroxetine binding to rat cortical membranes. Eur J Pharmacol 118:107-114, 1985 [PubMed]

Harder R, Bonisch H: Effects of monovalent ions on the transport of noradrenaline across the plasma membrane of neuronal cells (PC-12 cells). J Neurochem 45:1154-1162, 1985 [PubMed]

Heurteaux C, Lucas G, Guy N, et al: Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat Neurosci 9:1134-1141, 2006 [PubMed]

Henry LK, Defelice LJ, Blakely RD: Getting the message across: a recent transporter structure shows the way. Neuron 49:791-796, 2006 [PubMed] Hoffman BJ, Mezey E: Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain. FEBS Lett 247:453-462, 1989 [PubMed]

Hollmann M, Maron C, Heinemann S: N-Glycosylation site tagging suggests a three transmembrane domain topology for the glutamate receptor GluR1. Neuron 13:1331-1343, 1994 [PubMed]

Hoyer D, Pazos A, Probst A, et al: Serotonin receptors in the human brain, II: characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res 376:97-107, 1986 [PubMed]

Hoyer D, Hannon JP, Martin GR: Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533-554, 2002 [PubMed]

Hrdina PD, Pappas BA, Roberts DC, et al: Relationship between levels and uptake of serotonin and high affinity [3H]imipramine recognition sites in the rat brain. Can J Physiol Pharmacol 63:1239-1244, 1985 [PubMed]

Hrdina PD, Foy B, Hepner A, et al: Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter. J Pharmacol Exp Ther 252:410-418, 1990 [PubMed]

Humphrey PP, Hartig P, Hoyer D: A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 14:233-236, 1993 [PubMed]

Innocenti B, Parpura V, Haydon PG: Imaging extracellular waves of glutamate during calcium signaling in cultured astrocytes. J Neurosci 20:1800-1808, 2000 [PubMed]

Inoue E, Mochida S, Takagi H, et al: SAD: a presynaptic kinase associated with synaptic vesicles and the active zone cytomatrix that regulates neurotransmitter release. Neuron 50:261-275, 2006 [PubMed]

Jacobs BL, Abercrombie ED, Fornal CA, et al: Single-unit and physiological analyses of brain norepinephrine function in behaving animals. Prog Brain Res 88:159-165, 1991 [PubMed]

Jacobs BL, Praag H, Gage FH: Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry 5:262-269, 2000 [PubMed]

Ji Y, Pang PT, Feng L, et al: Cyclic AMP controls BDNF-induced TrkB phosphorylation and dendritic spine formation in mature hippocampal neurons. Nat Neurosci 8:164-172, 2005 [PubMed]

Kanashiro CA, Khalil RA: Signal transduction by protein kinase C in mammalian cells. Clin Exp Pharmacol Physiol 25:974-985, 1998 [PubMed] Kandel ER, Schwartz JH, Jessell TM: Principles of Neural Science. New York, McGraw-Hill, 2000

Kaupmann K, Huggel K, Heid J, et al: Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. Nature 386:239-246, 1997 [PubMed]

Kellendonk C, Simpson EH, Polan HJ, et al: Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49:603-615, 2006 [PubMed]

Kim SF, Huang AS, Snowman AM, et al: From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase. Proc Natl Acad Sci U S A 104:3456-3459, 2007 [PubMed]

Kimelberg HK, Katz DM: High-affinity uptake of serotonin into immunocytochemically identified astrocytes. Science 228:889-891, 1985 [PubMed]

Kleim JA, Chan S, Pringle E, et al: BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex. Nat Neurosci 9:735-737, 2006 [PubMed]

Klein PS, Melton DA: A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A 93:8455-8459, 1996 [PubMed] Kornhauser JM, Greenberg ME: A kinase to remember: dual roles for MAP kinase in long-term memory. Neuron 18:839-842, 1997 [PubMed]

Krystal JH, Anand A, Moghaddam B: Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia. Arch Gen Psychiatry 59:663-664, 2002 [PubMed]

Kulkarni J, Garland KA, Scaffidi A, et al: A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology 31:543-547, 2006 [PubMed]

Laeng P, Pitts RL, Lemire AL, et al: The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J Neurochem 91:238-251, 2004 [PubMed]

Langer SZ, Moret C, Raisman R, et al: High-affinity [3H]imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine. Science 210:1133-1135, 1980 [PubMed]

Laporte AM, Koscielniak T, Ponchant M, et al: Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands. Synapse 10:271-281, 1992 [PubMed]

Larner AC, Keightley A: The Jak/Stat signaling cascade: its role in the biological effects of interferons, in Signaling Networks and Cell Cycle Control: The Molecular Basis of Cancer and Other Diseases. Edited by Gutkind JS. Totowa, NJ, Humana Press, 2000, pp 393-409

Lawrence JA, Charters AR, Butcher SP, et al: 5-HT transporter antibodies as a tool in serotonergic synaptosomal isolation. Biochem Soc Trans 23 (1, suppl):115S, 1995a

Lawrence JA, Charters AR, Butcher SP, et al: Recognition of 5-HT transporter by antipeptide antibodies. Biochem Soc Trans 23 (3, suppl):473S, 1995b Lee JL, Di Ciano P, Thomas KL: Disrupting reconsolidation of drug memories reduces cocaine-seeking behavior. Neuron 47:795-801, 2005 [PubMed] Lisman JE, McIntyre CC: Synaptic plasticity: a molecular memory switch. Curr Biol 11(19):R788-R791, 2001

Liu QS, Pu L, Poo MM: Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons. Nature 437:1027-1031, 2005 [PubMed]

Liu YF, Albert PR: Cell-specific signaling of the 5-HT1A receptor: modulation by protein kinases C and A. J Biol Chem 266:23689-23697, 1991 [PubMed]

Liu YL, Fann CS, Liu CM, et al: More evidence supports the association of PPP3CC with schizophrenia. Mol Psychiatry 12:966-974, 2007 [PubMed]

Lopez-Gimenez JF, Mengod G, Palacios JM, et al: Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907. Naunyn Schmiedebergs Arch Pharmacol 356:446-454, 1997 [PubMed]

Lu L, Hope BT, Dempsey J, et al: Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nat Neurosci 8:212-219, 2005 [PubMed]

Lummis SC, Beene DL, Lee LW: Cis-trans isomerization at a proline opens the pore of a neurotransmitter-gated ion channel. Nature 438:248-252, 2005 [PubMed]

Madden DR: The structure and function of glutamate receptor ion channels. Nat Rev Neurosci 3:91-101, 2002 [PubMed]

Maeng S, Zarate CA, Du J, et al: Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 63:349-352, 2008 [PubMed]

Malberg JE, Eisch AJ, Nestler EJ, et al: Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20:9104-9110, 2000 [PubMed]

Malenka RC, Nicoll RA: Long-term potentiation—a decade of progress? Science 285:1870-1874, 1999 [PubMed] Malinow R, Malenka RC: AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 25:103-126, 2002 [PubMed] Mangelsdorf D, Thummel C, Beato M, et al: The nuclear receptor superfamily: the second decade. Cell 83:835-839, 1995 [PubMed] Manji HK: G proteins: implications for psychiatry. Am J Psychiatry 149:746-760, 1992 [PubMed]

Manji HK, Lenox RH: Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol Psychiatry 46:1328-1351, 1999 [PubMed]

Manji HK, Drevets WC, Charney DS: The cellular neurobiology of depression. Nat Med 7:541-547, 2001 [PubMed]

Martin KC, Michael D, Rose J, et al: MAP kinase translocates into the nucleus of the presynaptic cell and is required for long-term facilitation in Aplysia. Neuron 18:899-912, 1997 [PubMed]

Martinowich K, Manji HK, Lu B: New insights into BDNF function in depression and anxiety. Nat Neurosci 10:1089-1093, 2007 [PubMed]

Matsubara M, Kusubata M, Ishiguro K, et al: Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions. J Biol Chem 271:21108-21113, 1996 [PubMed]

Matthews EK: Calcium and membrane permeability. Br Med Bull 42:391-397, 1986 [PubMed]

McCann UD, Thorne D, Hall M, et al: The effects of l-dihydroxyphenylalanine on alertness and mood in alpha-methyl-para-tyrosine-treated healthy humans: further evidence for the role of catecholamines in arousal and anxiety. Neuropsychopharmacology 13:41-52, 1995 [PubMed]

McEwen BS: Stress and hippocampal plasticity. Annu Rev Neurosci 22:105-122, 1999 [PubMed]

McMahon FJ, Burnevich S, Charney DS, et al: Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet 78:804-814, 2006 [PubMed]

Meltzer HY: Action of atypical antipsychotics. Am J Psychiatry 159:153-154; discussion 154-155, 2002

Mendels J, Chernik DA: The effect of lithium carbonate on the sleep of depressed patients. Int Pharmacopsychiatry 8:184-192, 1973 [PubMed]

Mermelstein PG, Becker JB, Surmeier DJ: Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J Neurosci 16:595-604, 1996 [PubMed]

Meyer-Franke A, Wilkinson GA, Kruttgen A, et al: Depolarization and cAMP elevation rapidly recruit TrkB to the plasma membrane of CNS neurons. Neuron 21:681-693, 1998 [PubMed]

Miller RJ: The control of neuronal Ca2+ homeostasis. Prog Neurobiol 37:255-285, 1991 [PubMed]

Minichiello L, Calella AM, Medina DL, et al: Mechanism of TrkB-mediated hippocampal long-term potentiation. Neuron 36:121-137, 2002 [PubMed] Miwa JM, Stevens TR, King SL, et al: The prototoxin lynx1 acts on nicotinic acetylcholine receptors to balance neuronal activity and survival in vivo. Neuron

51:587-600, 2006 [PubMed]

Möhler H, Fritschy JM, Rudolph U: A new benzodiazepine pharmacology. J Pharmacol Exp Ther 300:2-8, 2002 [PubMed]

Moore GJ, Bebchuk JM, Parrish JK, et al: Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness. Am J Psychiatry 156:1902-1908, 1999 [Full Text] [PubMed]

Mulligan SJ, MacVicar BA: VRACs CARVe a path for novel mechanisms of communication in the CNS. Sci STKE (357):pe42, 2006

Murase S, Mathe JM, Grenhoff J, et al: Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization. J Neural Transm Gen Sect 91:13-25, 1993 [PubMed]

Murphy TH, Blatter LA, Bhat RV, et al: Differential regulation of calcium/calmodulin-dependent protein kinase II and p42 MAP kinase activity by synaptic transmission. J Neurosci 14(3, pt 1):1320-1331, 1994

Nagatsu T, Mogi M, Ichinose H, et al: Changes in cytokines and neurotrophins in Parkinson's disease. J Neural Transm Suppl 60:277-290, 2000 [PubMed] Nestler EJ: Antidepressant treatments in the 21st century. Biol Psychiatry 44:526-533, 1998 [PubMed]

Nestler EJ, Hyman SE, Malenka RC: Molecular Neuropharmacology: A Foundation for Clinical Neuroscience. New York, McGraw-Hill, 2001

Neves-Pereira M, Mundo E, Muglia P, et al: The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family based association study. Am J Hum Genet 71:651-655, 2002 [PubMed]

Ni C, Murphy P, Golde TE, et al: 7-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294:2179-2181, 2001 [PubMed] Nicholls DG: Proteins, Transmitters and Synapses. Cambridge, MA, Blackwell Science, 1994

Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614, 1992 [PubMed]

Niswender CM, Sanders-Bush E, Emeson RB: Identification and characterization of RNA editing events within the 5-HT2C receptor. Ann N Y Acad Sci 861:38-48, 1998 [PubMed]

Owens MJ, Nemeroff CB: The serotonin transporter and depression. Depress Anxiety 8 (suppl 1):5-12, 1998

Pacholczyk T, Blakely RD, Amara SG: Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350:350-354,

1991 [PubMed]

Panatier A, Theodosis DT, Mothet JP, et al: Glia-derived D-serine controls NMDA receptor activity and synaptic memory. Cell 125:775-784, 2006 [PubMed]

Parnas H, Segel LA: Facilitation as a tool to study the entry of calcium and the mechanism of neurotransmitter release. Prog Neurobiol 32:1-9, 1989 [PubMed]

Patapoutian A, Reichardt LF: Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol 11:272-280, 2001 [PubMed]

Pazos A, Palacios JM: Quantitative autoradiographic mapping of serotonin receptors in the rat brain, I: serotonin-1 receptors. Brain Res 346:205-230, 1985 [PubMed]

Pearson Murphy BE, Steinberg SI, Hu FY, et al: Neuroactive ring A-reduced metabolites of progesterone in human plasma during pregnancy: elevated levels of 5ft-dihydroprogesterone in depressed patients during the latter half of pregnancy. J Clin Endocrinol Metab 86:5981-5987, 2001

Pessiglione M, Seymour B, Flandin G, et al: Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 442:1042-1045, 2006 [PubMed]

Pierce RC, Bari AA: The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity. Rev Neurosci 12:95-110, 2001 [PubMed]

Pineyro G, Blier P: Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol Rev 51:533-591, 1999 [PubMed]

Pisano P, Samuel D, Nieoullon A, et al: Activation of the adenylate cyclase-dependent protein kinase pathway increases high affinity glutamate uptake into rat striatal synaptosomes. Neuropharmacology 35:541-547, 1996 [PubMed]

Plyte SE, Hughes K, Nikolakaki E, et al: Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim Biophys Acta 1114:147-162, 1992 [PubMed]

Poo MM: Neurotrophins as synaptic modulators. Nat Rev Neurosci 2:24-32, 2001 [PubMed]

Przybyslawski J, Roullet P, Sara SJ: Attenuation of emotional and nonemotional memories after their reactivation: role of beta adrenergic receptors. J Neurosci 19:6623-6628, 1999 [PubMed]

Rajkowska G: Cell pathology in mood disorders. Semin Clin Neuropsychiatry 7:281-292, 2002 [PubMed]

Rapoport SI: In vivo fatty acid incorporation into brain phospholipids in relation to plasma availability, signal transduction and membrane remodeling. J Mol Neurosci 16:243-261; discussion 279-284, 2001

Rapport M, Green AR, Page I: Serum vasoconstrictor (serotonin): isolation and characterization. J Biol Chem 176:1248-1251, 1947

Rashid AJ, So CH, Kong MM, et al: D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci U S A 104:654-659, 2007 [PubMed]

Rasmussen H: The calcium messenger system (I). N Engl J Med 314:1094-1101, 1986 [PubMed] Rasmussen H: The cycling of calcium as an intracellular messenger. Sci Am 261:66-73, 1989 [PubMed]

Rasmussen K, Morilak DA, Jacobs BL: Single unit activity of locus coeruleus neurons in the freely moving cat, I: during naturalistic behaviors and in response to simple and complex stimuli. Brain Res 371:324-334, 1986a

Rasmussen K, Strecker RE, Jacobs BL: Single unit response of noradrenergic, serotonergic and dopaminergic neurons in freely moving cats to simple sensory stimuli. Brain Res 369:336-340, 1986b

Ravid R, Van Zwieten EJ, Swaab DF: Brain banking and the human hypothalamus—factors to match for, pitfalls and potentials. Prog Brain Res 93:83-95,

1992 [PubMed]

Reader TA: Microiontophoresis of biogenic amines on cortical neurons: amounts of NA, DA and 5-HT ejected, compared with tissue content. Acta Physiol Lat Am 30:291-304, 1980 [PubMed]

Riccio A, Pierchala BA, Ciarallo CL, et al: An NGF-TrkA-mediated retrograde signal to transcription factor CREB in sympathetic neurons. Science 277:1097-1100, 1997 [PubMed]

Rick CE, Ye Q, Finn SE, et al: Neurosteroids act on the GABA(A) receptor at sites on the N-terminal side of the middle of TM2. Neuroreport 9:379-383, 1998 [PubMed]

Rink TJ: A real receptor-operated calcium channel? Nature 334:649-650, 1988 [PubMed]

Roberson ED, English JD, Sweatt JD: A biochemist's view of long-term potentiation. Learn Mem 3:1-24, 1996 [PubMed]

Roberson ED, English JD, Adams JP, et al: The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus. J Neurosci 19:4337-4348, 1999 [PubMed]

Robinson MJ, Stippec SA, Goldsmith E, et al: A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr Biol 8:1141-1150, 1998 [PubMed]

Roman T, Schmitz M, Polanczyk G, et al: Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am J Med Genet 105:471-478, 2001 [PubMed]

Roth BL, McLean S, Zhu XZ, et al: Characterization of two [3H]ketanserin recognition sites in rat striatum. J Neurochem 49:1833-1838, 1987 [PubMed]

Roybal K, Theobold D, Graham A, et al: Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci U S A 104:6406-11, 2007 [PubMed]

Rupprecht R: Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 28:139-168, 2003 [PubMed]

Sakaba T, Stein A, Jahn R: Distinct kinetic changes in neurotransmitter release after SNARE protein cleavage. Science 309:491-494, 2005 [PubMed] Salehi A, Verhaagen J, Swaab DF: Neurotrophin receptors in Alzheimer's disease. Prog Brain Res 117:71-89, 1998 [PubMed] Salinas PC: Wnt factors in axonal remodelling and synaptogenesis. Biochem Soc Symp 65:101-109, 1999 [PubMed] Salinas PC, Hall AC: Lithium and synaptic plasticity. Bipolar Disord 1:87-90, 1999 [PubMed]

Sanacora G, Kendell SF, Levin Y, et al: Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms. Biol Psychiatry 61:822-825, 2007 [PubMed]

Sapolsky RM: The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 48:755-765, 2000 [PubMed]

Saxena PR, De Vries P, Villalon CM: 5-HT1-like receptors: a time to bid goodbye. Trends Pharmacol Sci 19:311-316, 1998 [PubMed]

Schoeffter P, Bobirnac I: 5-Hydroxytryptamine 5-HT1D receptors mediating inhibition of cyclic AMP accumulation in Madin-Darby canine kidney (MDCK) cells. Naunyn Schmiedebergs Arch Pharmacol 352:256-262, 1995 [PubMed]

Schoepp DD: Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J Pharmacol Exp Ther 299:12-20, 2001 [PubMed]

Scott JA, Crews FT: Down-regulation of serotonin2, but not of D-adrenergic receptors during chronic treatment with amitriptyline is independent of stimulation of serotonin2 and ß-adrenergic receptors. Neuropharmacology 25:1301-1306, 1986 [PubMed]

Scott MM, Marcus JN, Elmquist JK: Orexin neurons and the TASK of glucosensing. Neuron 50:665-667, 2006 [PubMed]

Shaltiel G, Chen G, Manji HK: Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. Curr Opin Pharmacol 7:22-26, 2007 [PubMed]

Shaltiel G, Maeng S, Malkesman O, et al: Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania. Mol Psychiatry 13:858-872, 2008 [PubMed]

Simonds WF: Dysfunction of G protein-regulated pathways and endocrine diseases, in Signal Transduction and Human Disease. Edited by Finkel T, Gutkind JS. New York, Wiley, 2003, pp 201-231

Sklar P, Gabriel SB, McInnis MG, et al: Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neurotrophic factor. Mol Psychiatry 7:579-593, 2002 [PubMed]

Sleight AJ, Carolo C, Petit N, et al: Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. Mol Pharmacol 47:99-103, 1995 [PubMed]

Soderling TR: CaM-kinases: modulators of synaptic plasticity. Curr Opin Neurobiol 10:375-380, 2000 [PubMed]

Soltesz I, Staley K: High times for memory: cannabis disrupts temporal coordination among hippocampal neurons. Nat Neurosci 9:1526-1533, 2006 Spiegel AM: G Proteins, Receptors, and Disease. Totowa, NJ, Humana Press, 1998

Squire LR, Bloom FE, McConnell SK, et al: Fundamental Neuroscience. New York, Academic Press, 2003 Stabel S, Parker PJ: Protein kinase C. Pharmacol Ther 51:71-95, 1991 [PubMed]

Stambolic V, Ruel L, Woodgett JR: Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 6:1664-1668, 1996 [PubMed]

Stoof JC, Kebabian JW: Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci 35:2281-2296, 1984 [PubMed] Szabo ST, Blier P: Response of the norepinephrine system to antidepressant drugs. CNS Spectr 6:679-684, 2001 [PubMed]

Szabo ST, Du J, Gray N, et al: Mood stabilizer lithium regulates the synaptic and total protein expression of AMPA glutamate receptors in vitro and in vivo. Annual IRP Scientific Retreat, 2002

Taber MT, Fibiger HC: Electrical stimulation of the medial prefrontal cortex increases dopamine release in the striatum. Neuropsychopharmacology 9:271-275, 1993 [PubMed]

Tejani-Butt SM, Ordway GA: Effect of age on [3H]nisoxetine binding to uptake sites for norepinephrine in the locus coeruleus of humans. Brain Res 583:312-315, 1992 [PubMed]

Tejani-Butt SM, Brunswick DJ, Frazer A: [3H]Nisoxetine: a new radioligand for norepinephrine uptake sites in brain. Eur J Pharmacol 191:239-243, 1990


Truss M, Beato M: Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev 14:459-479, 1993 [PubMed] Tsao P, von Zastrow M: Downregulation of G protein-coupled receptors. Curr Opin Neurobiol 10:365-369, 2000 [PubMed] Ungerstedt U: Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand Suppl 367:1-48, 1971 [PubMed] Van Tol HH, Wu CM, Guan HC, et al: Multiple dopamine D4 receptor variants in the human population. Nature 358:149-152, 1992

Weisstaub NV, Zhou M, Lira A, et al: Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 313:536-540, 2006 [PubMed]

Westphal RS, Sanders-Bush E: Reciprocal binding properties of 5 hydroxytryptamine type 2C receptor agonists and inverse agonists. Mol Pharmacol 46:937-942, 1994 [PubMed]

Whitaker-Azmitia PM, Shemer AV, Caruso J, et al: Role of high affinity serotonin receptors in neuronal growth. Ann N Y Acad Sci 600:315-330, 1990 [PubMed]

Wiklund L, Bjorklund A: Mechanisms of regrowth in the bulbospinal serotonin system following 5,6-dihydroxytryptamine induced axotomy, II: fluorescence histochemical observations. Brain Res 191:109-127, 1980 [PubMed]

Wisner A, Dufour E, Messaoudi M, et al: Human opiorphin, a natural antinociceptive modulator of opioid-dependent pathways. Proc Natl Acad Sci U S A 103:17979-17984, 2006 [PubMed]

Wolf WA, Bobik A: Effects of 5,6-dihydroxytryptamine on the release, synthesis, and storage of serotonin: studies using rat brain synaptosomes. J Neurochem 50:534-542, 1988 [PubMed]

Wolff DJ, Poirier PG, Brostrom CO, et al: Divalent cation binding properties of bovine brain Ca2+-dependent regulator protein. J Biol Chem 252:4108-4117, 1977 [PubMed]

Woodgett JR: Judging a protein by more than its name: gsk-3. Sci STKE (100):RE12, 2001

Xu Q, Fawcett TW, Gorospe M, et al: Induction of mitogen-activated protein kinase phosphatase-1 during acute hypertension. Hypertension 30(1, pt 1):106-111, 1997

Yau JL, Noble J, Seckl JR: Acute restraint stress increases 5-HT7 receptor mRNA expression in the rat hippocampus. Neurosci Lett 309:141-144, 2001 [PubMed]

Zarate CA Jr, Singh J, Carlson PJ, et al: A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856-864, 2006a

Zarate CA Jr, Singh J, Manji HK: Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatry 59:1006-1020, 2006b

Zarate CA Jr, Singh J, Carlson PJ, et al: Efficacy of a protein kinase c inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Bipolar Disord 9:561-570, 2007; erratum in: Bipolar Disord 9:932, 2007

Zuckerman M: Sensation seeking, mania, and monoamines. Neuropsychobiology 13:121-128, 1985 [PubMed]

Copyright © 2009 American Psychiatric Publishing, Inc. All Rights Reserved.

Stop Anxiety Attacks

Stop Anxiety Attacks

Here's How You Could End Anxiety and Panic Attacks For Good Prevent Anxiety in Your Golden Years Without Harmful Prescription Drugs. If You Give Me 15 minutes, I Will Show You a Breakthrough That Will Change The Way You Think About Anxiety and Panic Attacks Forever! If you are still suffering because your doctor can't help you, here's some great news...!

Get My Free Ebook

Post a comment